Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M C Sullivan

Showing results (41-50 of 43) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 43 results.
Journal of Affective Disorders|August 7, 2013
A clinical predictive score for mood disorder risk in low-income primary care settingsP A Vöhringer, M I Jimenez, M A Igor, et al.
Osteoarthritis and Cartilage|January 28, 2014
OARSI guidelines for the non-surgical management of knee osteoarthritisT E McAlindon, R R Bannuru, M C Sullivan, et al.
Plos One|June 7, 2023
CCX559 is a potent, orally-administered small molecule PD-L1 inhibitor that induces anti-tumor immunityKathleen M C Sullivan, Marta Vilalta, Linda S Ertl, et al.
Pageof 5

Showing results (41-50 of 43) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 43 results.
Journal of Affective Disorders|August 7, 2013
A clinical predictive score for mood disorder risk in low-income primary care settingsP A Vöhringer, M I Jimenez, M A Igor, et al.
Osteoarthritis and Cartilage|January 28, 2014
OARSI guidelines for the non-surgical management of knee osteoarthritisT E McAlindon, R R Bannuru, M C Sullivan, et al.
Plos One|June 7, 2023
CCX559 is a potent, orally-administered small molecule PD-L1 inhibitor that induces anti-tumor immunityKathleen M C Sullivan, Marta Vilalta, Linda S Ertl, et al.
Pageof 5